In 2021 alone, it is estimated there will be 1.9 million new cancer cases. With so many new cases added every year, we are yet to find the optimal process for determining the right targeted treatment drugs for cancer patients. Solutions to this are few and far, and the trial period for finding the right drugs can be difficult for the patients.